Literature DB >> 6403462

Hemadsorption and virulence are separable properties of Mycoplasma pneumoniae.

D K Leith, E J Hansen, R M Wilson, D C Krause, J B Baseman.   

Abstract

A selective enrichment technique was used to isolate a hemadsorption-positive revertant of a hemadsorption-negative mutant strain of Mycoplasma pneumoniae. This hemadsorption-positive revertant was shown to have simultaneously regained both the ability to attach to neuraminidase-sensitive receptors on the tracheal ring respiratory epithelium in vitro and the ability to synthesize three virulent-strain-specific proteins which were not synthesized by the hemadsorption-negative mutant. Despite the persistence of the revertant in hamster lung tissue for 9 to 12 weeks postinfection, no cytopathology was observed. Intranasal inoculation of the revertant provided limited protection against a challenge dose of virulent M. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403462      PMCID: PMC348026          DOI: 10.1128/iai.39.2.844-850.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.

Authors:  G W Fernald; W A Clyde
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

2.  Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers.

Authors:  H Brunner; H B Greenberg; W D James; R L Horswood; R B Couch; R M Chanock
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

3.  Characteristics of virulent, attenuated, and avirulent Mycoplasma pneumoniae strains.

Authors:  R P Lipman; W A Clyde; F W Denny
Journal:  J Bacteriol       Date:  1969-11       Impact factor: 3.490

4.  The interrelationship of virulence, cytadsorption, and peroxide formation in Mycoplasma pneumoniae.

Authors:  R P Lipman; W A Clyde
Journal:  Proc Soc Exp Biol Med       Date:  1969-09

5.  Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence.

Authors:  D C Krause; D K Leith; R M Wilson; J B Baseman
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Hemadsorption and virulence of Mycoplasma pneumoniae.

Authors:  E J Hansen; R M Wilson; J B Baseman
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

7.  Antibodies in bronchial secretions following natural infection with Mycoplasma pneumoniae.

Authors:  G Biberfeld; G Sterner
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

8.  Attachment of Mycoplasma pneumoniae to respiratory epithelium.

Authors:  D A Powell; P C Hu; M Wilson; A M Collier; J B Baseman
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

9.  Characterization of hemadsorption-negative mutants of Mycoplasma pneumoniae.

Authors:  E J Hansen; R M Wilson; W A Clyde; J B Baseman
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Immunopathology of experimental Mycoplasma pneumoniae disease.

Authors:  W A Clyde
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

View more
  7 in total

1.  Protein P200 is dispensable for Mycoplasma pneumoniae hemadsorption but not gliding motility or colonization of differentiated bronchial epithelium.

Authors:  Jarrat L Jordan; How-Yi Chang; Mitchell F Balish; Lynley S Holt; Stephanie R Bose; Benjamin M Hasselbring; Robert H Waldo; Thomas M Krunkosky; Duncan C Krause
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

2.  Reacquisition of specific proteins confers virulence in Mycoplasma pneumoniae.

Authors:  D C Krause; D K Leith; J B Baseman
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

3.  Role of superoxide anion in host cell injury induced by mycoplasma pneumoniae infection. A study in normal and trisomy 21 cells.

Authors:  M Almagor; I Kahane; S Yatziv
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

4.  Adherence, fibronectin binding, and induction of cytoskeleton reorganization in cultured human cells by Mycoplasma penetrans.

Authors:  J A Girón; M Lange; J B Baseman
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

5.  In vitro spatial and temporal analysis of Mycoplasma pneumoniae colonization of human airway epithelium.

Authors:  Oliver A Prince; Thomas M Krunkosky; Duncan C Krause
Journal:  Infect Immun       Date:  2013-11-18       Impact factor: 3.441

6.  Inhibition of host cell catalase by Mycoplasma pneumoniae: a possible mechanism for cell injury.

Authors:  M Almagor; S Yatziv; I Kahane
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

Review 7.  Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae.

Authors:  Tsutomu Yamazaki; Tsuyoshi Kenri
Journal:  Front Microbiol       Date:  2016-05-23       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.